SCN9A: Sodium channel protein type 9 subunit alpha
Pore-forming subunit of Nav1.7, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes.
- Drugs that act on it: 7
- Approved: 0
- In phases 1 to 3: 7
- Sponsors: 3
Who is on it, and how far along
Every drug ChEMBL records acting on SCN9A, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 3
- Other 4
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
- AstraZeneca Pharmaceuticals114%
- Biogen114%
- Pfizer114%
| Vixotrigine | Phase 3 | Biogen | Small molecule | Blocker | 0 |
| PF-05089771 | Phase 2 | Pfizer | Small molecule | Blocker | 0 |
| AZD3161 | Phase 1 | AstraZeneca Pharmaceuticals | Other | Blocker | 0 |
| DSP-2230 | Phase 1 | — | Small molecule | Blocker | 0 |
| RG6029 | Phase 1 | — | Other | Blocker | 0 |
| RG7893 | Phase 1 | — | Other | Blocker | 0 |
| XEN403 | Phase 1 | — | Other | Blocker | 0 |
- Primary erythermalgia0.82
- Paroxysmal extreme pain disorder0.79
- Channelopathy-associated congenital insensitivity to pain, autosomal recessive0.74
- Hereditary sensory and autonomic neuropathy type 20.66
- Epilepsy0.65
- Seizure0.64
- Pain0.61
- Bipolar disorder0.61
- Major depressive disorder0.60
- Lennox-Gastaut syndrome0.60
- Atrial fibrillation0.59
- Focal epilepsy0.59
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4296, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt Q15858, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets